Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Response to Hepatitis B Vaccine in Egyptian Chronic Hepatitis C Patients

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Prospective Study of Changes in Anti-HCV Immunoglobulin G Antibody Titers after Treatment with Direct Acting Antiviral Agents

Effect of Treatment of Hepatitis C by Directly Acting Antivirals (DAA) on Chronic Hepatitis C, B Coinfected Patients

Long-term Follow-up of Chronic Hepatitis C Patients Treated by Direct- Acting Antivirals

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients

Impact of IL28B Polymorphism on the Response to Treatment of Hepatitis C with Interferon Based Therapy or Direct Acting Antivirals